Clinical Trial Update: Hypofractionated SBRT For Prostate Cancer [NA]

View source ↗

Summary

A clinical trial investigating hypofractionated stereotactic body radiotherapy for prostate cancer has completed, and results were posted on 2024-05-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Adam Olson | Conditions: Prostate Cancer | NA | Status: COMPLETED | Results posted: 2024-05-02